Product Information
ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $9.8758 per ML under NDC 00548560800. Its NADAC has been published 273 times since Jan 8, 2020.
Strength
300 mg/3mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548560800
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208600On Market Since
11/11/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 273 times since Jan 8, 2020, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8758 per ML |
|---|---|
| All-time high | $23.2005 (Apr 15, 2020) |
| All-time low | $9.8758 (Jun 17, 2026) |
| 52-week high | $11.6405 |
| 52-week low | $9.8758 |
| Median price | $12.5053 |
| Average price | $13.1568 |
| Largest weekly change | -32.2% (Apr 22, 2020) |
| Weeks tracked | 273 |
| Tracking since | Jan 8, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Amphastar Pharmaceuticals, Inc., is $9.8758 per ML (NDC 00548560800), effective Jun 24, 2026.
How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 57.4%. It has been tracked across 273 weekly CMS publications since Jan 8, 2020.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?
Since Jan 8, 2020, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $23.2005 (Apr 15, 2020), with a median of $12.5053 per ML.
Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ENOXAPARIN 300 MG/3 ML VIAL, but none are currently priced below it.
Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?
ENOXAPARIN 300 MG/3 ML VIAL (NDC 00548560800) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification